ALC

#375
Alcon Inc. Ordinary Shares
80.10 USD
+0.41%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
79.98
80.21
Range Annuel
71.55
99.20
Changement quotidien
+0.41%
Changement Mensuel
+3.57%
Evolution sur 6 mois
+8.07%
Changement Annuel
-12.81%
Clôture Précédente
79.77
Open
80.11
Bid
Ask
Low
79.98
High
80.21
Volume
413
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 39.04 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Nouvelles